China's first domestically developed anti-HIV drug to go global

0 申博电子游戏Print E-mail Xinhua, March 23, 2021
Adjust font size:

China's first domestically developed drug for the treatment of HIV infection has been approved by the health authority of Ecuador to access the country's market, according to pharmaceutical producer Frontier Biotech.

Aikening, or albuvirtide for injection (ABT), was approved by China Food and Drug Administration in 2018. It can be used with other antiretroviral drugs to treat HIV patients, according to Frontier Biotech, which is based in the east Chinese city of Nanjing.

The market access to Ecuador is the new drug's first overseas market entry.

Data from clinical trials show that Aikening is effective against major strains of HIV, including resistant viruses, and the efficacy is long-lasting.

The Chinese company said now it plans to export the drug to more than 60 countries in Asia, Africa, Europe and South America.

The global anti-HIV drug market grew from 22.9 billion U.S. dollars in 2013 to 34 billion U.S. dollars in 2018, and is expected to further expand to 46.7 billion U.S. dollars by 2023. 

Follow China.org.cn on Twitter and Facebook to join the conversation.
ChinaNews App Download

Go to Forum >>0 Comment(s)

No comments.

Add your comments...

  • User Name Required
  • Your Comment
  • Enter the words you see:    
    Racist, abusive and off-topic comments may be removed by the moderator.
网站地图 太阳城代理 极速百家乐 百家乐登入网址 申博太阳城直营网
申博游戏网址 菲律宾申博官方网址 菲律宾申博娱乐管理网 申博游戏网站登入
申博娱乐 澳门金沙娱乐场 太阳城亚洲开户 申博游戏下载
澳门银河赌场 申博官方网址 幸运大转盘 星级百家乐
申博游戏注册 申博游戏 太阳城申博 太阳城娱乐登入